Sort
50,496 grants matching “lung cancer”
Clinical trials employing cancer vaccine combination therapies
$787,127James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
$787,070William J Steinbach · Duke University · R01 · FY2020 · AI
Development of Novel Targeted Chemotherapeutics for the Treatment ofMalignant Pleural Mesothelioma
$787,067Frank L Sorgi · Flag Therapeutics, Inc. · R44 · FY2017 · CA
Occupational Exposure Assessment
$786,835Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Identification of Gene Polymorphisms Associated with Infectious Diseases
$786,549Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
$786,485Louise C Showe · Wistar Institute · U01 · FY2018 · CA
Molecular Epidemiology of Human Lung Cancer
$786,156Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Nudging Provider Adoption of Clinical Decision Support: Implementation of an EHR-Agnostic Pulmonary Embolism Risk Prediction Tool
$785,951Safiya Richardson · New York University School Of Medicine · R01 · FY2024 · HL
NYU Core Grant for Cardiovascular Faculty Recruitment
$785,863Glenn I Fishman · New York University School Of Medicine · P30 · FY2009 · HL
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$785,611Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2025 · AI
Water for Health: Strengthening Tribal Action for Cancer Prevention
$785,499Anne E Nigra · University Of Oklahoma Hlth Sciences Ctr · U19 · FY2024 · MD
Epidemiology of Putative Causal Variants in the Multiethnic Cohort
$785,130Loic Le Marchand · University Of Hawaii At Manoa · U01 · FY2012 · HG
Molecular Analysis of Breast Cancer Metastasis to the Brain
$785,037Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Molecular Biology of the Metastatic Phenotype
$785,037Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Carcinogenesis of Nickel and Epigenetic Control
$785,000Max Costa · New York University School Of Medicine · R01 · FY2009 · ES
Novel Pathogen Associated Cancers (PQ12)
$784,723Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
Crystallographic studies of macromolecular structures
$784,642Lars Pedersen · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Impact of Cellular and Extracellular Host Components on Tumor Progression
$784,417Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2011 · CA
Ancillary Study: Identification of Plasma Biomarkers in COPD
$784,389Steven G Kelsen · Temple Univ Of The Commonwealth · RC2 · FY2009 · HL
One-carbon metabolism and immune cell function in tuberculosis
$784,181Lanbo Shi · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Core Support for Vision Research
$784,179Michael Ellis Goldberg · Columbia University Health Sciences · P30 · FY2011 · EY
The Worcester Venous Thromboembolism Study
$784,114Frederick A Spencer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · HL
Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation
$784,016Howard Levin · Coridea, Llc · R44 · FY2022 · CA
Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation
$783,896Howard Levin · Coridea, Llc · R44 · FY2021 · CA
Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules
$783,845Eric L Grogan · Vanderbilt University Medical Center · R01 · FY2023 · CA